new standard for treating stage 4 egfr nsclc
Published 6 years ago • 684 plays • Length 5:14Download video MP4
Download video MP3
Similar videos
-
1:25
current treatment recommendations and future directions for egfr-mutant nsclc
-
1:57
new treatment option for egfr mutated lung cancer
-
0:48
new standard of care for lung cancer patients with egfr mutations
-
6:08
flaura study: a new standard of care for patients with egfr mutated nsclc
-
0:59
new standard of care treatment for egfr exon 20 non-small cell lung cancer | dr. alexander spira
-
14:24
egfr-mutant lung cancer & treatment options | 2023 living with egfr-mutant lung cancer patient forum
-
58:47
15 years of advances in egfr mutant lung cancer
-
5:55
surgery options for nsclc & i-o therapy in egfr-mutations
-
1:02:40
new milestones and changing standards of care in early egfr-mutated nsclc
-
1:57
dr. piotrowska on treatment for egfr-mutant nsclc
-
7:09
treatment of metastatic egfr-positive nsclc
-
1:37
dr. yu on treatments for egfr-mutant lung cancer
-
6:50
osimertinib: a potential new standard of care for advanced egfr-mutated nsclc | suresh ramalingam
-
3:30
osimertinib for uncommon egfr mutations in nsclc
-
2:19
patient summary: egfr-mutant stage 4 lung adenocarcinoma
-
1:21
the future of treatment for egfr-positive lung cancer
-
41:23
multimodal management of early-stage nsclc: egfr-targeted therapy in perioperative settings
-
6:41
egfr-positive nsclc: treatment at progression
-
2:20
new target for treatment resistance after egfr inhibitors found in lung cancer study